Heat Biologics Issued Additional Patent on gp96 Combination Platform Therapy with T-cell Co-Stimulator Oct 7, 2020
Heat Biologics CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th Sep 9, 2020
Heat Biologic's COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies Aug 13, 2020
Heat Biologics COVID-19 Vaccine Demonstrates Immunogenicity Proof-of-Concept in Pre-Clinical Studies Jul 29, 2020
Heat Biologics Announces First Patient Treated in First-in-Human Clinical Trial of PTX-35 Jun 22, 2020
